证券代码：000691 证券简称：亚太实业 公告编号: 2023-076 甘肃亚太实业发展股份有限公司 关于聘任公司副总经理及变更内审部门负责人的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 甘肃亚太实业发展股份有限公司（以下简称"公司"）于 2023 年 8 月 8 日 召开第八届董事会第二十六次会议，审议通过了《关于聘任黎永亮为公司副总经 理的议案》和《关于聘任钟琴为公司副总经理兼内审部门负责人的议案》。现将 相关情况公告如下： 一、聘任公司副总经理的情况 为进一步提升公司管理水平，提高公司运营管理效率，结合公司实际情况， 根据公司总经理提名，经公司董事会提名委员会审核，公司董事会同意聘任黎永 亮先生（简历详见附件）和钟琴女士（简历详见附件）为公司副总经理，任期自 董事会通过之日起至第八届董事会届满为止。本次聘任黎永亮先生和钟琴女士为 公司副总经理，不会导致公司董事会中兼任公司高级管理人员的董事人数超过公 司董事总数的二分之一。 公司独立董事对上述事项发表了同意的独立意见。具体内容详见同日披露于 巨潮资讯网（www.cninfo.com.cn）的《 ...

证券代码：000691 证券简称：亚太实业 公告编号: 2023-073 甘肃亚太实业发展股份有限公司 第八届监事会第十九次会议决议公告 本公司及监事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、监事会会议召开情况 甘肃亚太实业发展股份有限公司（以下简称"公司"）第八届监事会第十九 次会议通知于 2023 年 7 月 28 日以书面送达及电子邮件的形式发出，会议于 2023 年 8 月 8 日在甘肃省兰州市城关区张掖路 87 号中广商务大厦 17 层公司会议室以 现场方式召开。本次会议应参加表决监事 3 名，实际参加表决监事 3 名，由公司 监事会主席陈启星先生召集并主持会议。本次会议的召开符合有关法律、行政法 规、部门规章、规范性文件和公司章程的规定。 二、监事会会议审议情况 1、审议通过了《2023 年半年度报告及摘要》 公司第八届监事会第十九次会议决议。 特此公告。 表决结果：同意 3 票，反对 0 票，弃权 0 票。 经认真审核，监事会认为：董事会编制和审议公司《2023 年半年度报告及 摘要》的程序符合法律、行政法规和中国证监会的规定，报告内容真实、准确、 ...

根据《企业内部控制基本规范》及其配套指引的规定和其他内部控制监管要求（以 下简称企业内部控制规范体系），结合本公司（以下简称公司）内部控制制度和评价办 法，在内部控制日常监督和专项监督的基础上，我们对公司2023年06月30日（内部控制 评价报告基准日）的内部控制有效性进行了评价。 一、重要声明 按照企业内部控制规范体系的规定，建立健全和有效实施内部控制，评价其有效性， 并如实披露内部控制评价报告是公司董事会的责任。监事会对董事会建立和实施内部控 制进行监督。经理层负责组织领导企业内部控制的日常运行。公司董事会、监事会及董 事、监事、高级管理人员保证本报告内容不存在任何虚假记载、误导性陈述或重大遗漏， 并对报告内容的真实性、准确性和完整性承担个别及连带法律责任。 公司内部控制的目标是合理保证经营管理合法合规、资产安全、财务报告及相关信 息披露真实完整，提高经营效率和效果，促进实现发展战略。由于内部控制存在的固有 局限性，故仅能为实现上述目标提供合理保证。此外，由于情况的变化可能导致内部控 制变得不恰当，或对控制政策和程序遵循的程度降低，根据内部控制评价结果推测未来 内部控制的有效性具有一定的风险。 二、内部控 ...

证券代码：000691 证券简称：亚太实业 甘肃亚太实业发展股份有限公司 投资者关系活动记录表 编号：2023 -001 | 投资者关系活动类别 | ☐特定对象调研 ☐分析师会议 | | --- | --- | | | ☐媒体采访 业绩说明会 | | | ☐新闻发布会 ☐路演活动 | | | ☐现场参观 | | | ☐其他（请文字说明其他活动内容） | | 参与单位名称及人员姓名 | 线上参与公司2022年度网上业绩说明会的全体投资者 | | 时间 | 2023年05月26日 15:30-17:00 | | 地点 | 价值在线（https://www.ir-online.cn/） | | 上市公司接待人员姓名 | 总经理 贾明琪 | | | 财务总监 杨伟元 | | | 独立董事 张金辉 | | | 董事会秘书 李小慧 1 .公司剥离房地产业务购买临港化工，其规模都是比较小的。 | | | 请问公司如何做大做强？ | | 投资者关系活动主要内容 | 答:投资者您好，公司目前主营业务为精细化工产品的研发、生 | | 介绍 | 产及销售。公司将坚持"转型发展、突出主业"的总基调，以现有 | | | 精细化工业务 ...

甘肃亚太实业发展股份有限公司（以下简称"公司"）已于 2023 年 4 月 27 日在巨潮资讯网上披露了《2022 年年度报告全文》及《2022 年年度报告摘要》。 为便于广大投资者更加全面深入地了解公司经营业绩、发展战略等情况，公司定 于 2023 年 5 月 26 日（星期五）15:30-17:00 在"价值在线"（www.ir-online.cn） 举办甘肃亚太实业发展股份有限公司 2022 年度网上业绩说明会，与投资者进行 会议召开时间：2023 年 5 月 26 日（星期五）15:30-17:00 会议召开方式：网络互动方式 会议召开地点：价值在线（www.ir-online.cn） 会议问题征集： 投 资 者 可 于 2023 年 5 月 26 日 前 访问网址 https://eseb.cn/14UvEYNag00 或使用微信扫描下方小程序码进行会前提 问，公司将通过本次业绩说明会，在信息披露允许范围内就投资者普遍 关注的问题进行回答。 沟通和交流，广泛听取投资者的意见和建议。 一、说明会召开的时间、地点和方式 会议召开时间：2023 年 5 月 26 日（星期五）15:30-17:00 会议召 ...

Financial Performance - The company's operating revenue for Q1 2023 was CNY 118,672,474.76, representing a 69.17% increase compared to CNY 70,151,114.63 in the same period last year[5] - Net profit attributable to shareholders was CNY 1,380,452.58, a significant turnaround from a loss of CNY 3,071,180.15 in the previous year, marking a 144.95% increase[5] - The net cash flow from operating activities improved to CNY 2,789,798.83, compared to a negative cash flow of CNY -8,422,576.02 in the same period last year, reflecting a 133.12% increase[5] - Total operating revenue for Q1 2023 reached ¥118,672,474.76, a significant increase of 69.3% compared to ¥70,151,114.63 in the same period last year[17] - Net profit for Q1 2023 was ¥4,360,096.57, a turnaround from a net loss of ¥4,658,401.17 in the previous year[18] - The net profit attributable to the parent company was CNY 1,380,452.58, compared to a loss of CNY 3,071,180.15 in the previous period[19] - The total comprehensive income attributable to the parent company was CNY 1,380,452.58, a decrease from a loss of CNY 3,071,180.15 in the previous period[19] - The basic and diluted earnings per share were both CNY 0.0043, recovering from a loss of CNY 0.0095 in the previous period[19] Assets and Liabilities - The company's total assets increased by 3.10% to CNY 726,151,614.98 from CNY 704,316,945.23 at the end of the previous year[5] - Total assets increased to ¥726,151,614.98, up from ¥704,316,945.23, marking a growth of 3.1%[15] - Total liabilities rose to ¥406,864,205.40, compared to ¥389,218,989.00 at the beginning of the year, an increase of 4.0%[15] Cash Flow - The company's cash and cash equivalents increased to ¥32,553,193.35 from ¥31,126,056.21 at the beginning of the year, reflecting a growth of 4.6%[15] - Cash and cash equivalents at the end of the period were CNY 27,589,215.56, up from CNY 13,764,791.33 in the previous period[22] - Operating cash inflow totaled CNY 74,730,901.99, an increase from CNY 64,646,160.56 in the previous period[21] - The cash flow from investing activities was negative CNY 3,147,355.60, compared to a negative CNY 1,462,203.43 in the previous period[21] - The cash flow from financing activities resulted in a net outflow of CNY 2,531,111.11, worsening from a net outflow of CNY 1,541,949.81 in the previous period[21] Shareholder Information - The total number of common shareholders at the end of the reporting period is 17,669[10] - The largest shareholder, Lanzhou Asia-Pacific Mining Group Co., Ltd., holds 9.95% of shares, totaling 32,177,295 shares[10] - The second-largest shareholder, Lanzhou Taihua Investment Holdings Co., Ltd., holds 6.99% of shares, totaling 22,583,700 shares[10] - Wang Yuqian, a natural person shareholder, holds 5.01% of shares, totaling 16,200,000 shares[10] - As of the report date, the combined shareholding of the controlling shareholder and its concerted action party is 54,760,995 shares, accounting for 16.94% of the total share capital[12] - Lanzhou Taihua Investment Holdings Co., Ltd. reduced its holdings by 6,400,000 shares through block trading in January and February 2023[12] - The share transfer agreement between Lanzhou Taihua and Wang Yuqian involved 16,200,000 shares at a price of 4.6965 yuan per share[12] - The company has a total of 26,500,000 shares pledged by major shareholders[10] Operational Highlights - The company reported a 372.15% increase in prepayments, reaching CNY 14,751,361.83, attributed to increased raw material purchases[8] - The company experienced a 26.21% increase in accounts receivable, totaling CNY 84,621,363.64, due to improved market conditions and increased sales[8] - The company recorded a 58.13% rise in financial expenses, amounting to CNY 3,201,337.68, primarily due to increased exchange losses[8] - The company reported a significant increase in construction in progress, which rose by 32.77% to CNY 16,984,858.53, reflecting ongoing technical transformation projects[8] Research and Development - The company reported a significant increase in research and development expenses, totaling ¥4,367,374.37, compared to ¥4,591,598.48 in the previous year[18] Market and Product Development - The report indicates that the company has not disclosed any new product or technology developments in this quarter[11] - There is no mention of market expansion or mergers and acquisitions in the current report[11]

Financial Performance - The company reported a total revenue of 4,195 million CNY for the year 2022, reflecting a significant growth compared to the previous year[6]. - The company's operating revenue for 2022 was CNY 548,195,991.37, representing a 5.11% increase compared to CNY 521,559,903.94 in 2021[22]. - The net profit attributable to shareholders decreased by 91.40% to CNY 1,393,534.55 from CNY 16,204,628.33 in the previous year[22]. - The net cash flow from operating activities was CNY 26,469,898.56, down 59.97% from CNY 66,129,660.20 in 2021[23]. - Basic earnings per share fell by 91.42% to CNY 0.0043 from CNY 0.0501 in 2021[23]. - Total assets at the end of 2022 were CNY 704,316,945.23, a decrease of 3.86% from CNY 732,585,730.35 at the end of 2021[23]. - The net assets attributable to shareholders increased by 3.95% to CNY 141,862,655.37 from CNY 136,475,576.49 in 2021[23]. - The company reported a significant decline in net profit after deducting non-recurring gains and losses, indicating ongoing operational challenges[23]. - The weighted average return on equity dropped to 1.00% from 14.67% in the previous year, reflecting reduced profitability[23]. Dividend and Shareholder Returns - The company plans not to distribute cash dividends or issue bonus shares for the fiscal year 2022[4]. - The company reported a positive profit for the period, but no cash dividend distribution plan was proposed[136]. - There were no stock incentive plans or employee stock ownership plans implemented during the reporting period[137]. Risk Management and Compliance - The management discussed potential risks and countermeasures in the "Future Development Outlook" section of the report, emphasizing the importance of risk awareness for investors[3]. - The company has received a qualified audit opinion from Lianda Certified Public Accountants for the fiscal year 2022, indicating some concerns regarding financial reporting[3]. - The company emphasizes compliance with environmental regulations and safety standards to mitigate risks associated with production and waste management[89]. - The company reported that all directors attended the required board meetings, with no instances of absenteeism affecting decision-making[124]. - The company has not engaged in any violations regarding external guarantees during the reporting period[170]. Strategic Development and Future Outlook - The company has outlined its future development strategies, which include market expansion and potential mergers and acquisitions, although specific targets were not disclosed[3]. - The company aims to become a full industry chain company in the fine chemical industry over the next 2-3 years, focusing on research, production, and sales[85]. - The company plans to adjust its product structure based on market demands to better meet customer needs over the next three years[85]. - The company will enhance R&D efforts and eliminate outdated equipment to maximize production capacity and achieve annual sales revenue targets[86]. - The company provided a positive outlook for 2023, projecting a revenue growth of 10% to 1.32 billion CNY[102]. - New product launches are expected to contribute an additional 200 million CNY in revenue in 2023[102]. - The company is focusing on market expansion, targeting a 25% increase in market share in the next fiscal year[102]. Research and Development - The company is actively pursuing new technologies and product innovations to drive future growth[118]. - Research and development investments increased by 30%, totaling 150 million CNY in 2022[102]. - The company has a strong R&D team with multiple patents, including 3 invention patents and 14 utility model patents, enhancing its competitive edge in the fine chemical industry[51]. Environmental Responsibility - The report highlights the company's commitment to social responsibility and environmental issues, although specific metrics were not detailed[8]. - The company has implemented comprehensive environmental protection measures, ensuring compliance with regulations and avoiding penalties[54]. - The company has invested a total of ¥38,306,261.94 in environmental governance and protection during the reporting period[152]. - The company has established a wastewater treatment facility with a capacity of 1,000 tons per day to handle all wastewater generated from production and domestic sources[149]. - The company has received no administrative penalties related to environmental issues during the reporting period[152]. Corporate Governance - The company maintains independence from its controlling shareholders in terms of assets, personnel, finance, and operations, ensuring autonomous business capabilities[97]. - The company has implemented a structured remuneration management system for its executives[119]. - The board's actions reflect a commitment to shareholder interests and adherence to regulatory requirements[126]. - The company has strengthened its internal control system, enhancing internal audit supervision and subsidiary management[138]. - The company has established a mechanism for regular visits with core customers to strengthen existing business and explore new opportunities[48]. Market Position and Competition - The overall fine chemical industry in China has a fine chemical rate of approximately 40%, indicating significant room for growth compared to developed countries with rates of 60%-70%[35]. - The company primarily engages in the research, production, and sales of pharmaceutical intermediates and pesticide intermediates, which are crucial for the pharmaceutical and agricultural sectors[33]. - The company employs a direct sales model targeting large pesticide, pharmaceutical, and chemical enterprises, utilizing various methods to establish customer relationships[48]. - The company has established stable relationships with numerous high-quality domestic and international clients, primarily large chemical enterprises[55]. Financial Obligations and Commitments - The company must pay 87,210,000 yuan for the remaining 30% of equity transfer within 10 working days after the audit report, or risk losing control of its subsidiary[88]. - The company has pledged to fulfill its commitments regarding the asset restructuring and ensure that compensation measures are effectively executed[159]. - The company will bear joint liability for any debts and costs incurred due to claims against Lingang Yanuo Chemical related to wastewater treatment issues[163]. Legal Matters - The company faced a lawsuit involving a claim of CNY 117,083,886.83, which was ultimately dismissed by the court, maintaining the original ruling[179]. - The company has appealed a civil judgment that dismissed its claims, with the appeal process ongoing[180]. - The company has not reported any significant litigation or arbitration matters that could impact its financial performance[179].

Financial Performance - The company's revenue for Q3 2022 reached ¥187,428,274.37, representing a 65.94% increase compared to the same period last year[5] - Net profit attributable to shareholders was ¥7,789,863.60, a significant increase of 178.67% year-on-year[5] - The basic earnings per share for the period was ¥0.0241, up 180.23% from the previous year[5] - Total operating revenue for the third quarter was CNY 400,716,935.24, an increase of 1.7% compared to CNY 393,386,649.96 in the same period last year[31] - Net profit for the period was CNY 15,502,823.32, a decrease of 62.8% compared to CNY 41,649,443.40 in the previous year[32] - The net profit attributable to shareholders of the parent company was CNY 5,046,467.53, down 72.7% from CNY 18,482,277.69 year-on-year[32] - Total comprehensive income for the period was CNY 15,502,823.32, a decrease from CNY 41,649,443.40 in the previous period[33] - Net profit attributable to the parent company was CNY 5,046,467.53, down from CNY 18,482,277.69 year-on-year[33] - Basic and diluted earnings per share were both CNY 0.0156, compared to CNY 0.0572 in the previous period[33] Assets and Liabilities - Total assets at the end of the reporting period were ¥721,852,936.45, a decrease of 1.47% from the end of the previous year[5] - Total assets amounted to CNY 721,852,936.45, slightly down from CNY 732,585,730.35 at the end of the previous period[29] - Total liabilities decreased to CNY 411,913,585.77 from CNY 432,279,145.80, reflecting a reduction of 4.8%[29] - The company's equity attributable to shareholders increased to CNY 141,527,114.85 from CNY 136,475,576.49, marking a growth of 3.9%[29] Cash Flow - The net cash flow from operating activities was ¥474,223.94, down 99.17% compared to the same period last year[9] - Cash inflow from operating activities totaled CNY 163,608,782.02, a decline from CNY 244,896,311.13 in the prior year[34] - Net cash flow from operating activities was CNY 474,223.94, significantly lower than CNY 57,467,008.64 in the same period last year[34] - Cash outflow from investing activities was CNY 3,045,220.74, compared to CNY 34,648,793.11 in the previous period[34] - Net cash flow from financing activities was -CNY 9,606,154.52, an improvement from -CNY 12,455,171.85 year-on-year[34] - The cash and cash equivalents at the end of the period stood at CNY 17,077,635.50, down from CNY 26,409,996.86 at the end of the previous period[34] - The company reported a decrease in cash inflow from financing activities, totaling CNY 33,107,118.17, compared to CNY 62,000,000.00 in the prior year[34] Shareholder Information - Total number of common shareholders at the end of the reporting period is 18,136[11] - The largest shareholder, Lanzhou Taihua Investment, holds 14.97% of shares, totaling 48,383,700 shares, with 42,976,500 shares pledged[11] - Lanzhou Asia-Pacific Mining Group holds 9.95% of shares, totaling 32,177,295 shares, all of which are pledged[11] - The top ten shareholders collectively hold significant stakes, with the largest three shareholders accounting for over 34% of total shares[11] - As of September 30, 2022, the controlling shareholder and its concerted parties held a total of 80,560,995 shares, accounting for 24.92% of the total share capital[25] Investment and Development - The company has increased its investment in ongoing technical transformation projects, resulting in a 328.29% increase in construction in progress[9] - Research and development expenses were CNY 11,934,432.14, a slight decrease from CNY 12,715,504.29 in the previous year[31] - The company has not disclosed any new product developments or market expansion strategies in the current report[11] Legal Matters - The company reported a total claim amount of CNY 117,083,886.83 against Beijing Dashi Investment Co., Ltd., including principal and interest[22] - The court dismissed the company's lawsuit regarding the claim against Dashi Investment Co., Ltd., with the case acceptance fee of CNY 627,219.43 to be borne by the company[23] - The company has been actively involved in legal proceedings to assert its claims against Dashi Investment Co., Ltd., with the case currently under review[22] Regulatory and Corporate Actions - The company plans to raise up to 200 million RMB through a non-public offering of A-shares at a price of 4.01 RMB per share[12] - The non-public offering will involve issuing no more than 49,875,311 shares[12] - The company has received approval from the China Securities Regulatory Commission for its non-public offering[16] - The company is extending the validity period of its previous non-public offering resolution until July 7, 2022[16] - The company has undergone significant changes in its capital structure, including the termination of a non-public offering of A shares[18] Operational Costs - The company's gross profit margin was impacted by rising raw material prices, leading to a 15.27% increase in operating costs year-to-date[9] - The company reported a 52.78% increase in taxes and surcharges due to higher sales volume[9] - Total operating costs rose to CNY 384,814,836.80, up 12.1% from CNY 343,403,694.29 year-on-year[31] - The company reported a financial expense of CNY 1,960,208.37, significantly lower than CNY 9,615,250.14 in the same period last year[31]

Corporate Governance - The company plans not to distribute cash dividends, issue bonus shares, or increase share capital from reserves[4] - The legal representative of the company is Ma Bing[15] - The company has confirmed that all board members attended the meeting to review the report[3] - The financial report is guaranteed to be true, accurate, and complete by the responsible persons[3] - There were no significant changes in the company's board of directors or management during the reporting period[70] - The company has not implemented any employee stock ownership plans or other incentive measures during the reporting period[72] - The actual controller and shareholders have committed to avoiding competition with the company, holding 32,220,200 shares, which represents 9.97% of the total share capital[85] - The company emphasizes maintaining the legal rights and interests of all shareholders[86] - The company will not engage in unfair conditions or gratuitous transactions with related parties[86] - The company has committed to measures to ensure the protection of minority investors' rights during its non-public stock issuance[95] Financial Performance - The company's operating revenue for the reporting period was ¥213,288,660.87, a decrease of 23.94% compared to ¥280,438,522.17 in the same period last year[20] - The net profit attributable to shareholders was -¥2,743,396.07, representing a decline of 117.49% from ¥15,686,876.77 in the previous year[20] - The net cash flow from operating activities was -¥2,254,286.76, down 104.80% from ¥46,949,173.37 in the same period last year[20] - The basic and diluted earnings per share were both -¥0.0085, a decrease of 117.53% from ¥0.0485 in the previous year[20] - The total assets at the end of the reporting period were ¥751,867,040.97, an increase of 2.63% from ¥732,585,730.35 at the end of the previous year[20] - The net assets attributable to shareholders decreased by 1.99% to ¥133,755,546.74 from ¥136,475,576.49 at the end of the previous year[20] - The company reported a net loss of CNY 3,743,396.17 for the first half of 2022, compared to a net loss of CNY 1,203,000.00 in the first half of 2021[160] - The total comprehensive income for the first half of 2022 was -1,466,973.43 CNY, contrasting with 34,540,590.29 CNY in the same period of 2021[162] Market and Industry Analysis - The company primarily engages in the research, production, and sales of pharmaceutical intermediates and pesticide intermediates[31] - The main products include pyridine derivatives and nitrated products, which are used in agriculture, pharmaceuticals, and feed additives[32] - The fine chemical industry in China has significant cost advantages in producing intermediates compared to developed countries, with a current fine chemical rate of approximately 40%[30] - The company's operating revenue for the reporting period was primarily due to the impact of the COVID-19 pandemic and the overall chemical industry environment[48] - The growth of Lingang Yanuo Chemical is closely tied to the development of the downstream pharmaceutical and agricultural industries, with potential adverse effects if market expansion falls short of expectations[64] Risk Management - The company has detailed potential risks and countermeasures in the report[3] - Major raw materials such as 3-methylpyridine, dimethyl sulfate, and urea constitute a significant portion of production costs, making the company vulnerable to fluctuations in raw material prices[64] - Lingang Yanuo Chemical benefits from a 15% corporate income tax rate as a high-tech enterprise, but changes in tax policies could negatively impact profitability[66] - The company has implemented measures to monitor raw material price fluctuations and expand its marketing efforts to mitigate risks associated with market competition and raw material costs[66] Environmental and Social Responsibility - The company emphasizes environmental protection, continuously improving its waste treatment technologies and equipment to meet regulatory standards, with no penalties from environmental authorities to date[44] - The company has established a three-level environmental risk accident prevention system to manage potential pollution incidents effectively[77] - The company has achieved compliance with environmental standards, with no significant environmental or social safety issues reported during the reporting period[79] - The company actively responds to environmental policies and has been recognized as a "provincial green factory" in 2021, receiving various certifications in August 2022[80] Shareholder Relations - The company will minimize related party transactions with subsidiaries and ensure fair operations at market prices when unavoidable[86] - The company promises to strictly adhere to commitments regarding the dilution of immediate returns from the asset restructuring[86] - The company will not infringe on the interests of shareholders and will comply with regulatory requirements from the China Securities Regulatory Commission[86] - The company has established measures to ensure that any necessary related party transactions are conducted transparently and in the best interest of shareholders[87] Future Outlook and Strategy - The company is focusing on expanding its market presence and developing new products to enhance future growth prospects[153] - The management provided a positive outlook for the second half of 2022, expecting continued growth in revenue and profitability[177] - The company plans to enhance its market expansion strategies, focusing on increasing its presence in key regions[174] - The company is exploring potential mergers and acquisitions to strengthen its competitive position in the industry[176] Legal and Compliance Matters - The company is involved in a lawsuit regarding a debt claim against Beijing Dashi Investment Co., Ltd., which is currently under trial[100] - The company’s controlling shareholder and actual controller have been listed as defendants due to litigation arising from unpaid loans[102] - The company has no significant litigation or arbitration matters affecting its financial position[99] - The company has not reported any bankruptcy reorganization matters during the reporting period[99] Financial Transactions and Capital Structure - The company conducted a non-public offering of A shares in 2020, raising up to 200 million yuan[110] - The company received approval from the China Securities Regulatory Commission (CSRC) for its non-public stock issuance on July 15, 2021[114] - The company decided to terminate the non-public stock issuance and related transactions on July 7, 2022[116] - The total guarantee amount approved for subsidiaries is 5,967 million, with an actual guarantee balance of 4,947 million[125]

Financial Performance - The company's operating revenue for Q1 2022 was ¥70,151,114.63, a decrease of 49.19% compared to ¥138,055,660.87 in the same period last year[3] - The net profit attributable to shareholders was a loss of ¥3,071,180.15, representing a decline of 137.72% from a profit of ¥8,142,890.27 in the previous year[3] - The net cash flow from operating activities was -¥8,422,576.02, a decrease of 351.87% compared to ¥3,343,996.70 in the same period last year[3] - The company reported an operating loss of CNY -4,835,023.72, compared to an operating profit of CNY 20,655,297.32 in the previous year[26] - Net profit for the quarter was CNY -4,658,401.17, a significant decline from CNY 17,403,330.27 in the same quarter last year[26] - The net profit attributable to the parent company for Q1 2022 was -3,071,180.15 CNY, compared to a profit of 8,142,890.27 CNY in the same period last year, indicating a significant decline[27] - The total comprehensive income for the parent company in Q1 2022 was -3,071,180.15 CNY, down from 8,142,890.27 CNY year-over-year[27] - The total comprehensive income for minority shareholders was -1,587,221.02 CNY, down from 9,260,440.00 CNY in the previous year[27] Assets and Liabilities - The company's total assets at the end of the reporting period were ¥735,222,465.89, an increase of 0.36% from ¥732,585,730.35 at the end of the previous year[3] - Total assets at the end of the quarter were CNY 735,222,465.89, slightly up from CNY 732,585,730.35 at the beginning of the year[22] - Current assets totaled CNY 262,415,282.50, an increase from CNY 256,570,696.27 at the start of the year[22] - Total liabilities rose to CNY 439,152,384.19, compared to CNY 432,279,145.80 at the beginning of the year[23] - The company’s equity attributable to shareholders decreased to CNY 133,619,564.49 from CNY 136,475,576.49[23] Cash Flow - Cash inflows from operating activities totaled 64,646,160.56 CNY, compared to 86,097,583.64 CNY in the same period last year, reflecting a decline of approximately 25%[29] - Cash outflows from operating activities were 73,068,736.58 CNY, down from 82,753,586.94 CNY year-over-year[29] - The net cash flow from investing activities was -1,462,203.43 CNY, compared to -849,063.25 CNY in the previous year, indicating increased investment outflows[30] - Cash inflows from financing activities were 33,107,118.17 CNY, while cash outflows were 34,649,067.98 CNY, resulting in a net cash flow of -1,541,949.81 CNY for financing activities[30] - The ending cash and cash equivalents balance was 13,764,791.33 CNY, slightly down from 13,789,650.92 CNY at the end of the previous year[30] Inventory and Expenses - The company reported a 93.80% decrease in tax payable, reflecting a drop in sales due to the impact of the COVID-19 pandemic and the Winter Olympics[5] - The company's inventory increased by 23.98% to ¥167,155,381.51, compared to ¥134,823,580.94 in the previous year, indicating a buildup of stock[5] - The company experienced a 46.43% decrease in prepaid expenses, which fell to ¥10,485,139.89 from ¥19,573,460.07 in the previous year[5] Investment and Financing Activities - The company plans to continue its investment in ongoing technical improvement projects, which saw a 74.12% increase in construction in progress to ¥3,957,568.59[5] - The company raised a total of up to 200 million yuan through a non-public offering of A-shares at a price of 4.01 yuan per share, with a maximum of 49,875,311 shares to be issued[10] - The company submitted a written response to the China Securities Regulatory Commission (CSRC) regarding feedback on its non-public offering application within the required 30 days[11] - The company received a second feedback notice from the CSRC on April 23, 2021, requiring further written explanations and responses within 30 working days[12] - The company successfully passed the review of its non-public offering application by the CSRC on June 28, 2021[14] - The company extended the validity period of its 2020 non-public offering resolution until July 7, 2022, as approved by the shareholders' meeting[15] Debt and Bankruptcy Monitoring - The company filed a claim for a total debt of 117,083,886.83 yuan against Beijing Dashi Investment Co., including principal of 70 million yuan and interest of 47,083,886.83 yuan[18] - The company is closely monitoring the bankruptcy proceedings of Dashi Company, as the debt amount has not yet been confirmed, making it difficult to estimate the impact on future profits[19]